登雲股份(002715.SZ):黃樹生生前所持股份已完成繼承過户手續
格隆匯 8 月 16日丨登雲股份(002715.SZ)公佈,公司於近日接到公司持股5%以上股東張弢、歐洪先、李盤生、羅天友、李區、黃樹生、陳潮漢、莫橋彩、鄧劍雄九名一致行動人(“九名一致行動人”)之一黃樹生的繼承人歐少蘭、黃啟通知,黃樹生生前所持股份已完成繼承過户手續。
根據《中華人民共和國繼承法》的相關規定並經廣東省懷集縣公證處公證,黃樹生生前持有的公司無限售條件流通股46.534萬股(佔公司總股本0.5058%)為夫妻共同財產,由其配偶歐少蘭分配23.267萬股(佔公司總股本0.2529%),剩餘23.267萬股(佔公司總股本0.2529%)由其兒子黃啟繼承,其他權益人自願放棄繼承權。上述股份繼承過户手續已在中國證券登記結算有限責任公司辦理完畢。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.